Latest News

Blocking key enzyme minimizes stroke injury, research finds

A drug that blocks the action of the enzyme Cdk5 could substantially reduce brain damage if administered shortly after a stroke, research suggests. The development of a Cdk5 inhibitor as an acute neuroprotective therapy has the potential to reduce stroke injury, researchers report.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Neural compensation in people with Alzheimer's-related protein

  • Using cerebral protection device during transcatheter aortic valve replacement can cut number of cerebral lesions

  • Sport, physical activity help against depression

  • Smoking, schizophrenia linked by alterations in brain nicotine signals

  • Myth about Parkinson's disease debunked

  • Neuroimaging technique identifies concussion-related brain disease in living brain

  • Slowed processing speed linked with executive deficits in multiple sclerosis

  • Slow to mature, quick to distract: ADHD brain study finds slower development of key connections

  • Combining Epilepsy Drug, Morphine Can Result in Less Pain, Lower Opioid Doses

  • EEG study findings reveal how fear is processed in the brain

  •